Which is more profitable, Bristol-Myers Squibb or Medtronic?

Bristol-Myers Squibb keeps more of every sale as profit.

Which grows faster, Bristol-Myers Squibb or Medtronic?

Medtronic grew its sales faster in recent years.

Which is cheaper, Bristol-Myers Squibb or Medtronic?

Bristol-Myers Squibb costs less for each unit of yearly profit (lower P/E).

Which has less debt, Bristol-Myers Squibb or Medtronic?

Bristol-Myers Squibb would need fewer years of earnings to pay off its debt.

Bristol-Myers SquibbBMYvs

MedtronicMDT

Bristol-Myers Squibb vs Medtronic stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Bristol-Myers Squibb is more profitable, is cheaper for its profits and has less debt. Medtronic grows faster.

Side by side

	Bristol-Myers Squibb	Medtronic
	$130 billion	$132 billion
	14.6%	13.2%
	+2.5%	+3.8%
	18.4×	27.4×
	2.4 years	2.7 years
	13.9%	7.2%
	4.4%	3.5%

Open Bristol-Myers Squibb Open Medtronic

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Bristol-Myers Squibb vs Novo Nordisk · Bristol-Myers Squibb vs Roche · Bristol-Myers Squibb vs Thermo Fisher Scientific · Bristol-Myers Squibb vs UnitedHealth · Medtronic vs Intuitive Surgical · Medtronic vs Johnson & Johnson · Medtronic vs Eli Lilly · Medtronic vs McKesson